3/15/2007

Mylan Laboratories said the FDA granted tentative approval for its generic version of Abbott Laboratories' Depakote. The drug is for treating migraine headaches, epileptic disorders and manic episodes associated with bipolar disorder.

Full Story:
Forbes

Related Summaries